Stern E - Search Results

1

Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors.

Gillet N, Vandermeers F, de Brogniez A, Florins A, Nigro A, François C, Bouzar AB, Verlaeten O, Stern E, Lambert DM, Wouters J, Willems L. Gillet N, et al. Among authors: stern e. Pathogens. 2012 Oct 8;1(2):65-82. doi: 10.3390/pathogens1020065. Pathogens. 2012. PMID: 25436765 Free PMC article.

2

Medicinal chemistry endeavors around the phytocannabinoids.

Stern E, Lambert DM. Stern E, et al. Chem Biodivers. 2007 Aug;4(8):1707-28. doi: 10.1002/cbdv.200790149. Chem Biodivers. 2007. PMID: 17712816 Review.

3

3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.

Urbach A, Muccioli GG, Stern E, Lambert DM, Marchand-Brynaert J. Urbach A, et al. Among authors: stern e. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. doi: 10.1016/j.bmcl.2008.05.081. Epub 2008 May 24. Bioorg Med Chem Lett. 2008. PMID: 18547805

4

Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.

Stern E, Muccioli GG, Millet R, Goossens JF, Farce A, Chavatte P, Poupaert JH, Lambert DM, Depreux P, Hénichart JP. Stern E, et al. J Med Chem. 2006 Jan 12;49(1):70-9. doi: 10.1021/jm050467q. J Med Chem. 2006. PMID: 16392793

5

Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.

Stern E, Muccioli GG, Bosier B, Hamtiaux L, Millet R, Poupaert JH, Hénichart JP, Depreux P, Goossens JF, Lambert DM. Stern E, et al. J Med Chem. 2007 Nov 1;50(22):5471-84. doi: 10.1021/jm070387h. Epub 2007 Oct 4. J Med Chem. 2007. PMID: 17915849

6

Preparative enantiomeric separation of new selective CB2 receptor agonists by liquid chromatography on polysaccharide-based chiral stationary phases: determination of enantiomeric purity and assignment of absolute stereochemistry by X-ray structure analysis.

Stern E, Goossens L, Retailleau P, Kauffmann B, Bonte JP, Depreux P, Goossens JF. Stern E, et al. Chirality. 2011 May;23(5):389-96. doi: 10.1002/chir.20939. Epub 2011 Mar 23. Chirality. 2011. PMID: 21433091

7

Chiral resolution of the enantiomers of new selective CB(2) receptor agonists by liquid chromatography on amylose stationary phases.

Stern E, Goossens L, Vaccher C, Bonte JP, Depreux P, Henichart JP, Goossens JF. Stern E, et al. J Pharm Biomed Anal. 2008 Apr 14;46(5):848-53. doi: 10.1016/j.jpba.2007.01.044. Epub 2007 Feb 3. J Pharm Biomed Anal. 2008. PMID: 17367983

8

NIR-mbc94, a fluorescent ligand that binds to endogenous CB(2) receptors and is amenable to high-throughput screening.

Sexton M, Woodruff G, Horne EA, Lin YH, Muccioli GG, Bai M, Stern E, Bornhop DJ, Stella N. Sexton M, et al. Among authors: stern e. Chem Biol. 2011 May 27;18(5):563-8. doi: 10.1016/j.chembiol.2011.02.016. Chem Biol. 2011. PMID: 21609837 Free PMC article.

9

Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+.

Hollis LS, Amundsen AR, Stern EW. Hollis LS, et al. Among authors: stern ew. J Med Chem. 1989 Jan;32(1):128-36. doi: 10.1021/jm00121a024. J Med Chem. 1989. PMID: 2909724

10

cis-diamineplatinum (II) complexes containing phosphono carboxylate ligands as antitumor agents.

Hollis LS, Miller AV, Amundsen AR, Schurig JE, Stern EW. Hollis LS, et al. Among authors: stern ew. J Med Chem. 1990 Jan;33(1):105-11. doi: 10.1021/jm00163a018. J Med Chem. 1990. PMID: 2296007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

919 results

Search Page